CSIMarket


Novelion Therapeutics Inc   (NVLN)
Other Ticker:  
 


 

Novelion Therapeutics Inc

NVLN's Financial Statements and Analysis



Novelion Therapeutics Inc narrowed first quarter of 2019 net loss per share of $-1.67 compare to net loss per share of $-1.76 recorded in the same quarter a year ago a decrease compare to $-1.03 realized in previous quarter.


first quarter of 2019
Earnings Per Share Revenues
$ -1.67 $  32 Mill
$+0.09     $+5M     +17.16 %



Novelion Therapeutics Inc 's Revenue rose by 17.16 % in first quarter of 2019 (Mar 31 2019) year on year, to $32 million and declined by -20.9 % sequentially.


Novelion Therapeutics Inc is

More on NVLN's Income Statement



Novelion Therapeutics Inc 's in thefirst quarter of 2019 recorded net loss of $-31.847 million, an improvement compare to net loss of $-32.828 million in I. Quarter a year ago.

Sequentially net loss advanced

More on NVLN's Growth

Novelion Therapeutics Inc Inventories
Inventories grew by 0.22 % to $13 million from I. Quarter a year ago, sequentially inventories rose by 5.19 %. NVLN's Cash flow In the first quarter of 2019 company's net cash flow was $7 million


Novelion Therapeutics Inc does not pay out common stock dividend.

In trailing twelve-month period Novelion Therapeutics Inc payed $ -1.29 cash per share, on a free-cash flow basis .


Tangible Book value fell to $ -16.45 per share from $ -15.27.

Company issued 0.09 million shares or 0.48 % in Mar 31 2019.


More on NVLN's Dividends

 Market Capitalization (Millions) 13
 Shares Outstanding (Millions) 19
 Total Debt (Millions $) 74
 Revenue (TTM) (Millions $) 135
 Net Income (TTM) (Millions $) -107
 Cash Flow (TTM) (Millions $) 0
 Capital Exp. (TTM) (Millions $) 0
 Dividend TTM ($) 0 $
 Dividend Yield TTM (%) -
 Employees (TTM) $ 134




Novelion Therapeutics Inc does not pay out common stock dividend.

In trailing twelve-month period Novelion Therapeutics Inc had negative $ -1.29 cash flow per share, on a free-cash flow basis .


Tangible Book value fell to $ -16.45 per share from $ -15.27.

Company issued 0.09 million shares or 0.48 % in Mar 31 2019.


More on NVLN's Balance Sheets

 Market Capitalization (Millions) 13
 Shares Outstanding (Millions) 19
 Total Debt (Millions $) 74
 Revenue (TTM) (Millions $) 135
 Net Income (TTM) (Millions $) -107
 Cash Flow (TTM) (Millions $) 0
 Capital Exp. (TTM) (Millions $) 0
 Dividend TTM ($) 0 $
 Dividend Yield TTM (%) -
 Employees (TTM) $ 134
   



Date modified: -0001-11-30T00:00:00+00:00





Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com